Management of Trapped Pleural Fluid
When fluid is trapped behind the lung (trapped lung syndrome), pleurodesis will likely fail, and a pleuroperitoneal shunt or indwelling pleural catheter should be inserted instead of attempting standard chemical pleurodesis. 1
Understanding Trapped Lung
Trapped lung occurs when the lung cannot fully re-expand after fluid removal due to:
- A cortex of malignant tissue or fibrosis covering the visceral pleura 1
- Lack of mediastinal shift on chest radiographs (suggesting the lung is fixed and cannot expand) 1, 2
- Persistent pleural space despite adequate drainage 1
This is a critical distinction because trapped lung is a contraindication to standard pleurodesis—the procedure will fail if the lung cannot fully expand and contact the parietal pleura. 1
Primary Treatment Approach
For Trapped Lung with Inadequate Re-expansion:
Insert a pleuroperitoneal shunt as the definitive treatment. 1 This approach:
- Allows continuous drainage of fluid from pleural space to peritoneal cavity 1
- Provides symptom relief even when lung expansion is impossible 1
- Can be performed via VATS or limited thoracotomy 1
Key management points:
- Have a shunt readily available when undertaking surgical treatment, as trapped lung may only be discovered intraoperatively 1
- Shunt occlusion occurs in 12% of patients and requires shunt replacement 1
- If infection is confirmed, long-term chest tube drainage is indicated instead of shunt replacement 1
Alternative: Indwelling Pleural Catheter
For patients who are not surgical candidates or prefer outpatient management:
- Long-term indwelling catheter drainage is suitable for the outpatient setting 1
- Provides modest success rates with intermittent drainage 1
- Risk of local infection and potential tumor seeding (particularly concerning in mesothelioma) 1
When Partial Pleurodesis May Still Be Attempted
Even with incomplete lung re-expansion, chemical pleurodesis should still be attempted if there is partial pleural apposition, as it may provide symptomatic relief. 2 However, success rates will be lower than with complete lung expansion 2.
Controlled Drainage Protocol:
Before any intervention, drain the effusion in a controlled fashion:
- Limit drainage to 1-1.5 L at one time to prevent re-expansion pulmonary edema 2, 3
- Stop immediately if patient develops chest discomfort, persistent cough, or vasovagal symptoms 2, 3
- Obtain chest radiograph after drainage to assess lung re-expansion 1, 2
Management of Loculated Trapped Fluid
If the trapped fluid is loculated (septated):
Administer intrapleural fibrinolytic therapy before attempting definitive management: 2
- Urokinase 100,000 IU daily for 3 days, OR
- Streptokinase 250,000 IU twice daily for three doses 2
- Results in >67% reduction in effusion size in 72% of patients 2
Surgical Options for Refractory Cases
If the above measures fail and the patient has good performance status:
Decortication with pleurectomy may be considered, but carries significant risks: 1
- The cortex of malignant tissue covering pleural surfaces may be removable by open thoracotomy 1
- Pleurodesis may then become possible after cortex removal 1
- Reported perioperative mortality is 12%, making patient selection critical 1
- Major surgical procedures (parietal pleurectomy, decortication) do not provide superior palliation compared to pleurodesis alone when pleurodesis is feasible 1
Common Pitfalls and How to Avoid Them
Do not attempt standard talc pleurodesis in patients with trapped lung—it will fail. 1 Signs suggesting trapped lung include:
- Absence of mediastinal shift toward the effusion on imaging 1, 2
- Persistent pleural space after adequate drainage 1
- Known mainstem bronchial occlusion 1
Do not rapidly drain large effusions. 2, 3 Re-expansion pulmonary edema is rare but serious, resulting from rapid expansion of collapsed lung—prevent by strict adherence to 1-1.5 L volume limitations 2, 3.
Do not withhold intervention attempts even if complete re-expansion cannot be achieved. 2 Partial pleurodesis or shunt placement still provides symptomatic benefit in most patients 2.